The use of the NIS reporter gene for optimizing oncolytic virotherapy
about
Positive radionuclide imaging of miRNA expression using RILES and the human sodium iodide symporter as reporter gene is feasible and supports a protective role of miRNA-23a in response to muscular atrophyPerfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic VirusesRobust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model.Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.Oncolytic Virotherapy: A Contest between Apples and Oranges.Oncolytic Viral Therapy for Mesothelioma.Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma.Comparative oncology evaluation of intravenous recombinant oncolytic Vesicular Stomatitis Virus therapy in spontaneous canine cancer.Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects.Designing and building oncolytic viruses.New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging
P2860
Q33664375-5538F86F-3917-4716-8376-0C957480475FQ36756897-EE533458-A922-4D15-A1E3-B8F92BF3D82DQ38734741-E563839C-19C6-4997-93F6-5FE1831763AFQ38754467-EEC00132-DC13-4353-9C1C-B08067EB0363Q38772380-B2ACCAED-BA57-4ABD-ACAC-9005134A44E6Q39133291-56359D71-EB17-4708-966A-59B4164405D9Q39230055-D4DE462F-8F41-49E0-85F5-2D82560CC50DQ40051845-C7096D58-4A8D-4463-9E93-FA4DE19A7850Q42219664-840185D8-B6EA-4910-B13B-1C327F23E929Q45324545-926FC462-9AD0-4A89-9C03-8BDCBD668DE1Q45866837-3264CE0F-4CF6-4EC4-B54C-7B685C87B3E6Q47152420-7B99E37E-D099-4F82-B060-76C158A8FA8DQ47547386-F8EB395B-EC9B-48D7-A90C-C7033BE68134Q58705363-3C1BCAB5-59A6-4F2E-9059-7409C46ED5EB
P2860
The use of the NIS reporter gene for optimizing oncolytic virotherapy
description
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@ast
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@en
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@nl
type
label
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@ast
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@en
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@nl
prefLabel
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@ast
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@en
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@nl
P2860
P921
P3181
P1476
The use of the NIS reporter gene for optimizing oncolytic virotherapy
@en
P2093
Amber Miller
Stephen J Russell
P2860
P3181
P356
10.1517/14712598.2016.1100162
P407
P5008
P577
2015-10-12T00:00:00Z
2016-01-01T00:00:00Z